Barchart.com
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Amplify Weight Loss Drug & Treatment ETF (THNR)

Amplify Weight Loss Drug & Treatment ETF (THNR)
11.62 x 3 35.51 x 1
Pre-market by (Cboe BZX)
22.20 -0.22 (-0.98%) 03/13/25 [NYSE Arca]
11.62 x 3 35.51 x 1
Pre-market 22.20 unch (unch) 20:00 ET
News & Headlines for Thu, Mar 13th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip Zacks Investment Research - Wed Jan 15, 11:06AM CST

Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss medicine...

OZEM : 24.04 (-1.39%)
IHE : 68.93 (-0.83%)
LLY : 801.65 (-2.46%)
MEDX : 27.97 (-0.77%)
PPH : 91.59 (+0.10%)
THNR : 22.20 (-0.98%)
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR Zacks Investment Research - Thu Oct 17, 2024

For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVO : 75.89 (+1.47%)
LLY : 801.65 (-2.46%)
HRTS : 29.45 (-0.87%)
PPH : 91.59 (+0.10%)
THNR : 22.20 (-0.98%)
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win Zacks Investment Research - Wed Oct 16, 2024

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global...

NVO : 75.89 (+1.47%)
LLY : 801.65 (-2.46%)
HRTS : 29.45 (-0.87%)
PPH : 91.59 (+0.10%)
THNR : 22.20 (-0.98%)
Tap the Weight-Loss Drug Market With These ETFs
Tap the Weight-Loss Drug Market With These ETFs Zacks Investment Research - Wed Sep 18, 2024

The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other companies are...

RHHBY : 42.8600 (-1.61%)
NVO : 75.89 (+1.47%)
LLY : 801.65 (-2.46%)
HRTS : 29.45 (-0.87%)
THNR : 22.20 (-0.98%)
OZEM : 24.04 (-1.39%)

Barchart Exclusives

Stock Index Futures Climb as U.S. Shutdown Risk Eases Barchart - 52 minutes ago
March S&P 500 E-Mini futures (ESH25) are up +0.80%, and March Nasdaq 100 E-Mini futures (NQH25) are up +1.01% this morning as optimism over the likely aversion of a U.S. government shutdown boosted sentiment. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals
Wed, Mar 26, 2025 5:00 PM UTC
Reserve Your Spot